• Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
  

PubMed=7954438
Allione A., Consalvo M., Nanni P., Lollini P.-L., Cavallo F., Giovarelli M., Forni M., Gulino A., Colombo M.P., Dellabona P., Hock H., Blankenstein T., Rosenthal F.M., Gansbacher B., Bosco M.C., Musso T., Gusella L., Forni G.
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.
Cancer Res. 54:6022-6026(1994)

PubMed=7989764; DOI=10.4049/jimmunol.153.12.5659
Pericle F., Giovarelli M., Colombo M.P., Ferrari G., Musiani P., Modesti A., Cavallo F., Di Pierro F., Novelli F., Forni G.
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.
J. Immunol. 153:5659-5673(1994)

PubMed=31783695; DOI=10.3390/cancers11121889; PMCID=PMC6966465
De Giovanni C., Nicoletti G., Landuzzi L., Palladini A., Lollini P.-L., Nanni P.
Bioprofiling TS/A murine mammary cancer for a functional precision experimental model.
Cancers (Basel) 11:1889.1-1889.20(2019)